Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes And the RSI is 14
Anything below 60 is considered Over Sold so at some point we're long over due to a major UP Swing just based on this alone!
Cheers
It's All Good Now! UP From Here!!
Ethema Acquisition Approved
10:01 AM ET 6/23/21
West Palm Beach, FL, June 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Ethema Health Corporation (OTC PINK: GRST) ("Ethema" "GRST" or the "Company") is pleased to announce that the Department of Children and Families of Florida has given the green light to the change of ownership for the ARIA treatment center and will be granting the new license early
next week, making the ownership change final. The Company will report further on the accounting treatment of this acquisition.
The Company also reports that it intends to report more regularly on its twitter page @healthethema and that those reports may contain disclosure that is key information in compliance with Regulation Fair Disclosure allowed by the SEC as per the SEC press release of April 2, 2013.
Mr. Shawn Leon, the CEO of the Company, stated, "We are pleased with the progress we have made on the debt reductions and restructuring that have taken place recently and are very excited that we can report the financial operations of our acquisition in the second quarter after the acquisition closes."
About Ethema Health Corporation
Ethema Health Corporation (OTCPINK: GRST) operates in the behavioral healthcare space specifically in the treatment of substance use disorders. Ethema developed a unique style of treatment over the last decade and has had much success with in-patient treatment for adults. Ethema will continue to develop world-class programs and techniques for North America. For more information you can visit our website at www.ethemahealth.com .
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For information please contact:
Ethema Health Corporation
Text to 416-500-0020
shawn@ethemahealth.com
Twitter @healthethema
> Dow Jones Newswires
June 23, 2021 10:01 ET (14:01 GMT)
I DON'T CARE...
and I didn't deny what you said.
ALL I'm saying is it's dated 6/23/21 FACT, NOTHING MORE!
Please chill
Gee That's Odd
It's dated 6/23/21
But nevertheless all the points I made are highly relevant to this company's Market Capacity AND positive forthcoming events.
New Article Out Today 6/23/21 - Regen Among Line Up of Rising Stars
https://www.scoopcube.com/global-cell-transplant-market-2021-key-vendors-regen-biopharma-global-cord-blood-corporation-cbr-systems-escape-therapeutics/
Listen, the space this company is in has to do with what I refer to as "Transformative Medicine" due to its Disruptive Biotechnology that is destined to re-shape the practice of Medicine the way we've know it for decades.
What does this mean ultimately??
Life threatening diseases that historically most people die from either being curable OR no longer being life threatening via advanced therapeutics coming to Market via scientific breakthroughs.
Regent owns the Patents of SEVERAL of these advanced biotechnologies EACH of which have a Billion Dollar Market Capacity! Don't let this FACT evade you.
Try to remember that advancements in any evolving Technology is NOT on a linear scale, it's geometric. That is an undeniable fact!
PROOF: Most advancements in modern civilization have been made within the past 100 Years, and as time is moving forward those advancements are increasing geometrically where life changing discoveries are happening at a much faster pace today than even 10 years ago. Regen is among these players in the biosciences industry, in fact they're among the leaders.
Don't let the current PPS fool you...it's a deliberate ploy by MMs holding it down for massive accumulation of shares to make themselves and their croonies behind the scenes Billionaires! They just don't want YOU to be one of them! WHY? GREED!!! GET IT??
PINK CURRENT COMING SOON THAT MAY RESULT IN AN UPGRADE TO OTCQB IF NOT A BUY OUT! If the latter occurs, you'll suddenly find your Shares on NASDAQ or NYSE trading under a Big Pharma ticker with a PPS North of $5.
The only question is which one first??
Be well and prosper....
Well said!
Right! Pink Current Is The Name Of That Tune
That's where "history will repeat itself" and then some!
Personally, I'm looking for a run to $1.00-to-$1.50 for starters!
For EN@C all it took was 19 trading days post Pink Current to hit $0.95.
Let's see if we do better in fewer days!
Be well and prosper...
EXCELLENT POST!
Well said!
Thank you
P.S. Koos might also be making all these aggressive moves preparing to sell the company based on that 8K he filed not long ago that gives him exclusive control over negotiations thereby preventing a Hostile Take Over by going around him to his Board. He's going to need an enormous amount of money to pour into bringing those patents to Market, so unless he has that kind of money laying around a Big Pharma Buy Out would be the only way that will happen. I don't know, may be the guy is a Billionaire or has access to that kind of money via his financing connections.
Either way, it's full steam ahead!!
Roger That!
It's all good now!
Be well and prosper...
Amazing 10-K Dropped TODAY 6/21/21!!!
https://sec.report/Document/0001607062-21-000165/
You may need an HOUR to read it! LOL!
Due to the extensiveness of it, if I didn't know any better this has either BUY OUT OR OTCQB Uplist written all over it!
It's going to definitely be one or the other or BOTH!!!
IMO, Up List FIRST followed by Buy Out!
Be well and prosper...
Big Push Coming Post Pink Current!
Who knows how high it will fly??
Be well and prosper...
Regen BioPharma Discovers Fundamental Role of NR2F6
https://www.biospace.com/article/releases/regen-biopharma-inc-discovers-fundamental-role-of-nr2f6-in-production-of-malignant-blood-vessels/
....and this was only the beginning.....
Be well and prosper...
EXCELLENT POST!
Nothing like a frank, honest, factual discussion!
mRNA....the Future of Medicine
Thank you
Portrait Of A Rising Global Super Star Poised For Greatness
Key Take-Away: Disruptive Biotechnology in the mRNA Therapeutics Space- The Future of Medicine
Regen BioPharma,Inc(OTCMKTS:RGBP)
Powerful Run Brewing As Company Looks to Crush the Competition
By Boe Rimes- June 14, 2021
Regen BioPharma is making an explosive move up the charts since reversing up off its base of $0.01. Microcap Daily initially covered RGBP in April 2021 when the stock skyrocketed from triple zeroes to highs of $0.081 after Regen and its subsidiary KLS entered into an agreement with Oncology Pharma, Inc. whereby Regen granted to Licensee an exclusive right and license for the development and commercialization of intellectual property for the treatment of pancreatic cancer for a term of fifteen years from April 7, 2021. The License IP consists of antigen specific cancer vaccines in which modified mRNA is administered to produce epitopes able to produce an immune response which augments likelihood of successful induction of immunity. An epitope is the part of an antigen that is recognized by the immune system.
Furthermore, The Company is currently in the process of updating its filings and preparing outstanding 10Q and 10k reports in order to up list to fully reporting OTCQB “Pink Current” Tier.
After a brief respite RGPB is making a power house move up the charts again looking to blaze a path along the likes of Enzolytics or Tesoro and break out into a whole new dimension – Tesoro went to multi-dollars and Enzolytics nearly hit $1.00 shortly after going Pink Current. RGBP is in beast mode right now and is the most talked about small cap stock; a break over $0.082 and its blue skies ahead.
RGBP buyout rumors abound; according to many investors it appears there may be a Potential Merger-Acquisition looming with Precigen OR another Big Pharma, and if so, it would make perfect sense for the following reasons: The CEO of Precigen (PGEN) Helen Sabzevari is on RGBP’s Scientific Advisory Board. PGEN trades on NASDAQ with a Market Cap of $1.3B and has an extensive clinical trials pipeline in Immunology-Oncology that includes development of mRNA vaccine therapies. https://precigen.com/about.
PGEN is in the same clinical therapeutic space of Oncology-Immunology candidate drug development that RGBP is in. 100% identical including the same mRNA vaccine technology. Therefore, logically speaking it would make sense if PGEN buys-out RGBP OR does a Merger Acquisition and the motive to do this are the numerous valuable Patents RGBP owns that have Billion Dollar Market Capacity. Recently we see Koos on an aggressive campaign to pull everything together about RGBP in the shortest amount of time to apparently ready the company for SALE! If you look closely at his recent actions it very clearly points to this.
Regen BioPharma is a publicly traded biotechnology company focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing small molecule therapies for treating cancer and autoimmune disorders by modulating the Checkpoint NR2F6.
The Company is also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax), modulating key molecular processes in cancer stem cell through its patented molecular targeting approaches (BORIS), and repairing damaged bone marrow in patients with aplastic anemia and chemotherapy/radiotherapy treated cancer patients (HemaXellerate). RGBP owns a valuable patent porfolio.
Regen has identified and filed patents on small molecules that activate and inhibit a novel gene (NR2F6) which controls how the immune system reacts to cancer cells and to inflammatory responses. The Company’s products include HemaXellerate, a personalized cellular therapeutic product designed to stimulate blood production in patients whose bone marrow is not properly functioning.
HemaXellerate uses patient’s own fat as source of endothelial cells to heal damaged bone marrow Aplastic Anemia Stem Cell Therapy – HemaXellerate – IND #15376 CLEARED TO PROCEED TO PHASE I / II CLINICAL TRIALS. The United States Food and Drug Administration Investigational New Drug Application cleared (IND #15376)
dCellVax Breast Cancer – dCellVax – IND #16200. CellVax is a dendritic cell based immunotherapy that stimulates the patient’s immune system through a process called “gene silencing.” Establishment of safety will allow for rapid expansion of patient numbers. Currently addressing FDA questions with Dr. Santosh Kesari, head of UCSD Neuro-Oncology program.
DiffronC – Myelodysplastic Syndrome Gene Silencing – DiffronC is a novel form of therapy called differentiation therapy that is expected to have much milder toxicity than chemotherapy. The mechanism of action is to correct the specific genes that prevent the myelodysplastic syndrome stem cell from producing mature blood cells. Silencing using DiffronC induces differentiation of cancer cells. Initial indication is treatment of myelodysplastic syndrome. Other indications include solid tumors and acute leukemia.
Telomeres & Genomic Integrity: Stem cells and cancer cells have found ways of maintaining their telomeres in a state that prevents senescence. Our research in to the cancer stem cell has given us a molecular pathway that can be manipulated to expand stem cells and maintain telomeres. Telomeres are protective structures at the ends of chromosomes that enable cell divisions. Telomere attrition is involved in aging, cancer and genetic mutations. The Company is developing drugs that modulate telomere maintenance. In pre-clinical development for indications of solid cancers and acute leukemia.
In the CBD space RGBP researchers have determined that combining its lead NR2F6 small molecule agonist with Cannabidiol (CBD) may provide a dynamic therapy for treating inflammatory bowel disease (IBD). Currently, there are a number of pre-clinical and clinical studies being conducted by other companies regarding pain management that suggest potential benefits of CBD. Regen believes that CBD may augment the Company’s small molecule therapies for autoimmune disorders, in this case specifically IBD.
IBD is a disease caused by persistent and chronic inflammation of the gastrointestinal tract and is a term that refers to both ulcerative colitis and Crohn’s disease. Current treatments include non-specific immune suppressors such as steroids as well as newer drugs recently approved by the FDA. The IBD market size is estimated at $6.7 billion global and projected to be $7.6 billion by 2023.There are currently no non-steroidal therapies available to IBD sufferers.
Recently it's been speculated that Koos intends to sell the company, and if so, let’s objectively review why that might be:
1). on 4/8/21 Koos files an 8K that in and of itself is a dead give-a-away of what he’s up to. The question begs why would he file an 8K that specifically gives himself exclusive control of voting rights in negotiations for the sale of the company during the bidding process that’s specifically intended to prevent a Hostile Take Over? And in doing this he states quote: “persons of interest who want to ACQUIRE RGBP must negotiate directly.” This is in reference to himself having sole control of voting rights that this 8K gives him. Other words, negotiations for sale of the company can’t go around him to his board which is a typical move in any hostile take over. This by itself reveals what he’s up to in addition to MANY other factors shown below. https://sec.report/Document/0001607062-21-000145/
2). he recently hired a Firm to get OTC current with FULL disclosure reporting. This has to do not only with SEC compliance to remain listed on the OTC beyond September 2021 but ALSO it provides transparency for any potential Big Pharma buyers that would never consider buying a company otherwise.
3). on 6/1/21 he files another 8K that has to do with resolving a lawsuit. This would be important to any potential buyers for reason a pending unresolved lawsuit would likely complicate negotiations of a buy out, or it would be a deterrent altogether. https://sec.report/Document/0001607062-21-000145/
4). we see him moving to get all his expired Patents updated. Logically this move would be consistent with preparing for an acquiring company to take over the patents then turn around and file an FDA IND post buy out in order to immediately place those candidate drug Patents in their clinical trials pipeline.
5). lastly he’s not updating the company website that’s been outdated for years. Why would he invested time, energy, and money in updating his company website if he’s about to sell the company?
This is not an attempt to read Koos' mind, however the cluster of all these moves he's made combined within a narrow time span seems highly indicative of an intention to sell the company and the revelation of that is rapidly forthcoming.
Link to above Article:
https://microcapdaily.com/regen-biopharma-inc-otcmkts-rgbp-powerful-run-brewing-as-company-looks-to-crush-the-competition-hemaxellerate/131947/?amp&__twitter_impression=true&fbclid=IwAR3NqAzavR7a27Ql0abPPUuvtSGSWz0MoWLfcL1De1-vxJyDc-Y-YR33dMU
It's called Sub-Licensing.
Go back and look at the filing of that deal.
RGBP Licensed to Oncology Pharma who then has the right to sub-license.
Congratulations!
Be well and prosperous...
GREAT NEWS!!
What that means is serious monthly or quarterly royalties to RBGP for 15 Years just on that ONE (1) licensing deal!
This is ALSO a major incentive for a Big Pharma acquisition of RBGP! i.e. built in revenue streams with several other RGBP Patents to apply for an IND and put in their clinical trials pipeline!
Be well and prosper...
Here's Another Thing!!!
IF RGBP is acquired by a Big Pharma, which I give better than a 60% probability IMO, you're going to be financially set for the rest of your life, in particular if you're holding at least 1 Million Shares! Some of you are holding WAY MORE than that!
In the mean time, don't let the crooked MMs psych you out with their mind game of shorting this stock to the ground AND holding it down over a prolonged period of time which they are well known for, because guess what, they're more interested in riding this UP than keep in down, AND the ONLY reason they're keeping it down is to massively accumulated shares for themselves at a rock bottom discount that they Shorted it to!
They've DECEIVED MANY investors by their game psyching them out of their shares and their hope is that you will SELL at a LOSS and say to yourself "forget about it" which goes directly in their pockets in the form of cheap shares!!!
It doesn't take a rocket scientist to figure this out! And here's another FACT, MMs can't handle any substantial massive BUYING PRESSURE!
Be well and prosper....things are about to change REAL SOON!!
PINK CURRENT IS THE NAME OF THAT TUNE STRAIGHT AHEAD!!
When that happens doors will open immediately to an increase number of trading platforms followed by a steady and consistent rise in the PPS which could then suddenly EXPLODE well into the Dollar-Multi Dollar range! This is ONLY an opinion but I firmly believe this is what is going to happen.....it did for EN*C within 19 trading days of going Pink Current when it rose to nearly $1.00, but yet it doesn't come anywhere close to comparing with RGBP!
Well said!
And with that what many don't realize here is this Play represents "Disruptive Biotechnology" that's just beginning to make its debut on the global scene now in the process of curing historically incurable deadly diseases...AND we are only at the FRONT DOOR to boot!
Anyone in this Play needs to really let that sink in for reason mRNA Therapeutics are the "FUTURE" of Medicine!!!
Soon we will be seeing an increase in the number of historically deadly diseases either completely cured AND a dramatic increase in long term survival with less morbidity, i.e. various forms of cancers, etc
Be well and prosper...
Yes, And They're Going to get MOWED DOWN When the ENORMOUS BUYING PRESSURE BEGINS!
...upon going Pink Current which could happen any day!
I know one thing about the crooked MMs, they can't handle ANY significant BUYING PRESSURE!!!
PPS EXPLOSION IMMINENT!!! - PINK CURRENT ANY DAY...!!!
..due to instant multiple trading platforms available for Buying!
Keep in mind EN*C shot UP to nearly $1 within 19 Trading days of going Pink Current plus nothing else whatsoever! i.e. No licensing on their ONLY Patent, No revenue nor prospect of revenue, No partnerships nor prospect of partnerships, No NOTHING!
The contrast to RGBP is no comparison on any level!
Not only this, the prospect of a BUY OUT-MERGER ACQUISITION handwriting is on the wall based on one of Koos 8-Ks and everyone here knows this!
Be well and prosper...
WoW! The $Dollar Volume Traded on 6/17/21 was $41.4 Million!
...and that was with 3 Billion Shares Traded!
Just think, this is only the beginning!
Cheers!
Well Said Jack!
And if I may I'd like to add to your great list a few items that some people here seem to easily lose sight of not taking responsibility and instead blame others for:
The OTC:
1) is an unregulated market
2) is very high risk
3) is highly volatile
4) OTC Message Boards Posters POST their OPINIONS that may or may NOT pan out, and those who disagree or question their OPINIONS should IGNORE their perspective
5) OTC Market Makers (ALL OF THEM) are PRIMARILY in it for THEMSELVES although they're responsible for "making a market" and AT WILL they routinely Naked Short Sell Stocks to the ground like what they did recently to the entire OTC where most OTC stocks lost 70% or more of their value; then they gradually begin BUYING BACK and run selected stocks right back up to the top much higher than before and Sell thereby reaping major profits in BOTH directions, and worse yet, the SEC let's them get away with it!
VERY LIKELY! IN FACT ALL OF THEM!!
You missed the entire point!
EPIC REVERSAL- PPS EXPLOSION IMMINENT!!!
If there ever was a time to LOAD UP IT'S NOW!!!!
Pink Current will be the game changer and that's about to happen any day. It will open the door to massive buying on MANY trading platforms!
Here's another thing, MMs have Shorted it DOWN and holding it DOWN for this very moment.
By now, most of you should know the MM's Game, i.e. massive profits Short Selling it Down (over an extended period), then Running it back UP selling at the top WAY HIGHER than when it all started! They make personal fortunes doing this.
IMO, we're directly in front of a possible DOLLARS or Multi-Dollars RUN UP that could occur in a single trading session! Don't think it can't happen, it can and does! Even if it doesn't, a substantial run UP will nevertheless occur that will take us easily to $1 or higher.
If there ends up being a Big Pharma Merger-Acquisition you'll suddenly find yourselves swimming in DOLLARS!!
As one Poster recently suggested, "this will dwarf EN*C." I couldn't agree more and recently posted a review on this.
Best wishes to all..
WRONG! The SEC DID NOT say that!
This is YOU saying this.
POST an SEC or OTC Markets Link THAT SAYS WHAT YOU ARE SAYING....
YOU CAN'T DO IT!
BUY OUT Handwriting On The Wall- Common Sense Required
Well said 29! I would even go so far as to say a sure thing; a far gone conclusion! Likely a Big Pharma merger-acquisition to grab ALL of RGBP's 22 or more Patents, including the two active ones presently in the production pipeline via the CRO Oncology Pharma for treating pancreatic & colon cancer!
IF NOT then why the 4/23/21 8-K that served only ONE (1) purpose, i.e. to PREVENT A HOSTILE TAKE OVER DURING NEGOTIATIONS FOR THE SALE OF THE COMPANY!!! Koos even uses the language "directly negotiate" in the filing.
https://www.otcmarkets.com/filing/html?id=14894907&guid=ilRnUKwBhM5Jhth
Does anyone suppose that Koos spent his time, energy, and resources to file that 8-K because he had nothing else better to do??
There really is no other way to look at this, and as far as I'm concerned the only question remaining is WHEN & HOW MUCH?
The answer to this question will no doubt unfold in the immediate wake of RGBP going Pink Current straight ahead..days to weeks from now prior to the SEC deadline of Sept 28, 2021.
According to the information provided on the OTC Markets Link below, full disclosures "should" (NOT MUST) be made by June 30th to "allow sufficient time to review and update market status for the filing companies...."THIS IS NOT THE DEADLINE SO DON'T ANYONE GET IT TWISTED!!!
https://www.otcmarkets.com/corporate-services/information-for-pink-companies
Is this making any sense? If not it should.
Be well and prosper...
In Anticipation of Going Pink Current....
...RGBP is starting its limb just like ENZC did in Mid-November 2020.
ENZC History Recap
On Nov 24th it hit 0.04 (UP from 0.0132 Nov 2nd).
Then on Dec 1st it hit 0.11.
Subsequently, on Jan 13, 2021, 29 trading days later it went Pink Current with a PPS of 0.125 thereby opening the doors WIDE to be traded on multiple platforms.
Then as a result of that,Ten (10) trading days later it more than DOUBLED and hit 0.2650 based entirely on going Pink Current (no news, no patent licensing, no partnerships, no nothing).
THEN, only 9 trading days later it EXPLODED TO 0.95!
IMO, we can fully anticipate at least the same if not far better with RGBP due to its Market Position of having (2) active patents licensed to Oncology Pharma (with sub-licensing provisions to Big Pharmas) and already in revenue when that deal became finalized. Then of course are its several other patents currently being revived, and a total of 22 or more patents in its portfolio!
Now sit back and watch the steady PPS climb in anticipation of going PINK CURRENT!!!.....and when it does...PPS EXPLOSION due to broad access to scores of trading platforms, period!
A TOTAL AND COMPLETE NO BRAINER!
Be well and prosper...
Pink Current = North of $1.00 EASILY WITHIN WEEKS!!!
WHY?
I'll again use a comparative analogy of ENZC Vs. RGBP (both Biophama development companies)
ENZC
(History)
Nov 2, 2020
PPS .0132
Not Pink Current but proactively moving in that direction
(1) Patent
No Licensing of Patent
No Partnerships
No Revenue
PPS began to rise Late Nov to early Dec 2020 in anticipation of going Pink Current.
On Nov 24th the PPS hit 0.04; a 67% increase from Nov 2nd. Then on
on Dec 1st 2020 the PPS went to 0.11; an additional 175% increase.
MOVING FORWARD
January 13, 2021
ENZC went Pink Current
PPS 0.125
No Licensing of Patent
No Partnerships
No Revenue
On Jan 27th 2021 the PPS more than doubled to 0.2650based solely on going Pink Current plus nothing else whatsoever. At this point there was a 1,907% increase in the PPS relative to Nov 2, 2020.
Moving forward on 2/9/2021 ENZC hit 0.958; a 666.4% increase in only 19 trading days AFTER going Pink Current!
AGAIN WHY?
Pink Current immediately results in broad access to multiple trading platforms, plain & simple.
* * * CONTRAST * * *
RGBP
June 11, 2021
PPS 0.0198
Not Pink Current but proactively moving in that direction
Presently reviving several of its 22 Patents (see 5/7/21 8K)
Has licensed (2) of its Active Patents:
#1- On April 7, 2021 Regen Biopharma, Inc, entered into an agreement with Oncology Pharma, Inc. whereby Regen granted an exclusive right and license for the development and commercialization of its Patent for treatment of pancreatic cancer. This Patent will be used to produce an antigen specific cancer vaccine in which modified mRNA will be administered to patients to confer immunity.
#2- On April 7, 2021 KCL Therapeutics, Inc.; a wholly owned subsidiary of Regen Biopharma, entered into an agreement with Oncology Pharma, Inc. whereby KCL granted an exclusive right and license for the development and commercialization of its Patent for the treatment of colon cancer.
As a result of these two licensing arrangements RGBP has already received up front payment in cash & stock from Oncology Pharma, and is guaranteed royalty payments for 15 Years for 10% of all proceeds generated from Licensing, and 5% for Sub-Licensing to 3rd Party Pharmaceutical Companies.
Oncology Pharma (ONPH) last traded at $31.81 this past Friday 6/11/21 and has a 52 Week High of $50. On its website, it lists RGBP as a "potential partner" in the space of Oncology Therapeutics.
https://www.oncology-pharma.com/news
Now based on these FACTS I believe it would be a reasonable assumption that with the anticipation setting in for RGBP going Pink Current within weeks from now (like what happened to ENZC), its PPS should be expected to rise in the same manner, if not MUCH HIGHER, than ENZC's run to 0.95, and this would be based on RBGP having Licensed TWO (2) PATENTS soon going into pharmaceutical production in the colon & pancreatic cancer treatment space utilizing the disruptive biotechnology of an mRNA Vaccine that at some point will undoubtedly go global..
It's time to start using some common sense here!
RGBP GOING PINK CURRENT IS THE NAME OF THAT TUNE IN AND OF ITSELF ALL BY ITSELF!
Then when its mRNA Vaccine Technology goes into mass production for global distribution there will undoubtedly be an EXPLOSION in its PPS to unimaginable heights, and YET there are several more of RGBP's Patents presently being revived with the prospect of licensing.
In closing, everyone in this play knows that Koos MUST get Pink Current BEFORE the SEC deadline September 28, 2021, and that all disclosures "should" be provided to the SEC by June 30, 2021. It was made very clear in recent PRs that he has hired a top drawer professional auditor to accomplish this by the deadline.
https://www.otcmarkets.com/corporate-services/information-for-pink-companies
Then on top of this he recently filed an 8K on 4/23/21 that protects RGBP from a Hostile Take Over in the event of a Buy Out, where any potential bidders are required to negotiate directly with himself being in full control of the Board due to is majority share position.Therefore the specter of a Buy Out by a Big Pharma might come in the wake of going Pink Current which is a real possibility.
https://www.otcmarkets.com/filing/html?id=14894907&guid=ezRnUpxpMbxhQth
With all of this in mind I fully anticipate RGBP's PPS to begin a steady and consistent rise this coming week 6/14/21 moving forward based on this SEC Mandate combined with ALL the above!
IMO, PPS well above $1 by Fall 2021 (if not sooner) which I believe is by FAR a reasonable assumption based on the provided comparative analogy presented in this post.
Bottom line is ENZC's Market position was no where near RGBP's current position when it made it's run to 0.95, not close by a long shot!
What was the fundamental and sole cause of this happening?? IT WENT PINK CURRENT instantly opening the door WIDE for trading on multiple platforms and within 19 trading days of that happening it hit nearly $1.00!!
I rest my case....all feedback welcome.
Be well and prosper...
RIGHT! LOW FLOAT! AND WHEN THAT HAPPENS ....
....the PPS should naturally rise due to supply being lower than demand
BUT it's important to keep in mind that the Market Maker can walk the PPS UP artificially to create sell off profit taking so that supply is freed up and then the PPS will begin to Fall OR they can engage in Naked Short Selling that will have the same effect.
Here's a link I found that will explain this in detail:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=50727775
Be well and prosper...
Moving UP Fast AGAIN On HIGH VOLUME!!
IMO, looks like we might be getting position for a Buy Out!
Either way when we go Pink Current shortly the PPS is going to rise sharply, WAY BETTER than ENZC this past January on its run to 0.95.
I fully expect RGBP to surpass $1.00 within days/weeks of going Pink Current for the reasons I previously posted, i.e. due to the door being open WIDE to MANY trading platforms people can BUY it on like I already stated.
Just plain common sense in comparison to ENZC that still has not licensed their Patent to a Big Pharma like RGBP which has actually licensed 2 Patents not 1 AND has already received initial proceeds.
Be well and prosper...
A Word From Shawn About Communicating With Shareholders!
6/9/21
Mr. Shawn Leon, the CEO of the Company, stated, "I am very pleased that the Labrys Fund has continued to show faith in the Company and I am very pleased to continue our aggressive pursuit of eliminating debt while building our business.
I have heard from many shareholders that they would like to hear from me more frequently and I am going to work on an effective method to accomplish this."
Be well and prosper...
Putting Things In Proper Perspective Of What's About To Happen!!
Let's have a little talk here to get the right perspective. I'll use a comparative analogy.
I was in Enzolytics (ENZC) this time last year, opened a position for nearly 3M Shares @0.01. They had no revenue (and still don't), big dilution, weren't even pink current. Suddenly they did a reverse merger with a small privately held biopharma not trading on any market and also no revenue.
By EOY ENZC got Pink Current. Then in Jan 2021 the PPS started moving up week after week, left copper and transitioned into silver. Then all the sudden it shot up to $0.95. The ONLY fundamental thing that changed was going Pink Current which of course opened the doors WIDE for their stock to be traded on MANY platforms. This was a MAJOR GAME CHANGER!!
Listen, Koos is no idiot, he knows he MUST get Pink Current, he's racing to pull everything together. Once that happens the pps will sky rocket!
Furthermore ENZC has only 1 Patent and is no where near generating revenue. RGBP has at least 25 Patents recently licensed one to Oncology Pharma currently trading at $26.50, and now RGBP is positioned to generate revenue! HUGE DIFFERENCE!!
These are the FACTS!!! Not only this, Koos might sell the company to a Big Pharma that would be even better!
AMEN!!!
...and so it shall be as you said (Mark 11:23)
Great Post!
Don't forget the 52% Insider Ownership!
Nearly $6 MILLION TRADED WITHIN 3 HOURS MARKET OPEN!
LOL!
Just jumped in today!
Glad I did!
Definite winner here!
Be well and prosper...
Thanks!
Ok, and how does that related to your statement "the offering being over?"
Thanks
Please Describe In What Way is the MM "Paul The Key"
...and since he's a Naked Short Seller what makes you think he's going to STOP and IF he does, how would that relate to the "Offering being over?"
Please enlighten me.
Thank you
Interesting Read on Stockwitz of Buy Out Speculation
This poster said:
@Imcliff- I don't think it's a typo., i.e. "RGBP Shares Held at DTC (0).
Everything else was updated for $RGBP as well on 6/04/2021...i.e. Market Cap, Authorized Shares, Outstanding Shares, Restricted & Unrestricted Shares. All of that stayed unchanged.
Only shares "Held at DTC" changed from 3,745,260,993 to now "zero". It seems there must be a reason for it to change like that all of a sudden.
I don't believe it would be for any bad reasons though. Probably has to do with something or everything the company has been working on with its auditors and/or maybe a pending change in ownership through a buyout, reorganization, and cusip number/symbol change which the company has yet to announce?
But who knows? We're all pretty much operating in the blind here while waiting on the company's filings and announcements. Best wishes
All feedback welcome.
Be well and prosper...
EXCELLENT POST!!!
Thanks for sharing that!
Although my GRST position isn't in the Six Figure Dollar range as of yet I'm nevertheless heavily vested well into the Multi-Million Share range and am adding to that often!
And the reason why?? Like you and many others here, I BELIEVE in this company and have the utmost confidence, respect, and appreciation for what Shawn has accomplished so far, given his stellar track record of business development and senior operations management. I believe what we are seeing is just the beginning of a much larger vision.
I commend you for your faith and bold stance to support this amazing company presently in its early growth phase to the utmost extent for reason of the very great need it fulfills in Healthcare, one that millions of people wouldn't survive otherwise.
I've already emoted about this previously sharing one such experience I'll never forget of a friend in Los Angeles back in the 80s (Vanity) who's life was tragically taken from her due to a long standing severe substance abuse addiction that she never got into treatment for.
But looking back on that she probably would not of recovered if she had of for reason there were no resident treatment facilities in existence at that time like Ethema Health. It was largely limited to ambulatory counseling sessions that included a limited degree of group therapy.
Fact is, the ambulatory treatment model has a very high failure/relapse rate that can actually cause the addiction to increase even with slightly higher suicide rates due mainly to the looming element of hopelessness and acute toxicity. I have even had ambulatory patients tell me they would prefer death as opposed to cycling through continuous relapses.
Sustained daily administration of multi-phasic scaled modalities and interpersonal bonding with highly qualified therapists and other residents in treatment in a "community setting" is absolutely essential for any chance of success and this is what makes Ethema Health's addiction recovery model highly effective.
As I've said before, "it's the only one that works."
In closing, I wish to express a need for supporters vested in this company to please be patient as things are progressing behind the scene and to try not to be too critical of Shawn.
Although he doesn't communicate often I'd rather for him to do that than not focusing on the daily operations of this company with the very large responsibilities he has and not just with daily operations, but working on scaling the Ethema Vision beyond where it is today that I believe is headed for regional expansion, then National.
Patients is key here as is prayer.
Lastly, I'm confident that overall Economic and Stock Market conditions including the OTC are on track to improve near term as the economy is re-starting and with this we will see a vast difference upon entering the 3rd & 4th quarters of this year.
I believe as revenues are consistently falling to this company's bottom line Q over Q there will be a very definite and consistent rise in the PPS.
Be well and prosper...